PMON57 Impact of Injection Modalities on Real-World Injection Experience in Patients with Acromegaly or Neuroendocrine Tumors (NETs) Treated With Somatostatin Analog (SSA) Therapy: Data from the PRESTO 2 Survey

INTRODUCTION: Long-acting (LA) SSA therapy is a common first-line medical treatment for acromegaly or NETs. Real-world data on patients’ injection experience with the latest LA SSA devices/formulations are limited. AIMS: PRESTO 2 assessed injection experience among patients treated with lanreotide a...

Descripción completa

Detalles Bibliográficos
Autores principales: Ribeiro-Oliveira, Antonio, O’toole, Dermot, Kunz, Pamela, Houchard, Aude, Boiziau, Sandra, Prebtani, Ally, Webb, Susan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Neuroendocrinology and Pituitary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625390/
http://dx.doi.org/10.1210/jendso/bvac150.1157

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625390/
http://dx.doi.org/10.1210/jendso/bvac150.1157

Ejemplares similares